Completed Access to Information Requests 2019

Month Request Number Request Summary Disposition Number of Pages
January 2019 A-201901-02 All meeting minutes, presentations and speaking notes associated with the following 2018 meetings of the Patented Medicine Prices Review Board Steering Committee on Modernization of Price Review Process Guidelines and the working group struck to inform that committee: July 26, August 15, August 22, August 24, September 12, September 25, October 12, December 13 May 4, 2019 144
A-2019-01-01 The draft recommendations made by the Working Group to inform the Patented Medicine Prices Review Board Steering Committee on Modernization of Price Review Process Guidelines sent for external review and any supporting documents sent to the reviewer May 5, 2019 77
February 2019 Nothing to Report
March 2019 A-2018-00823 Joint DMS- IMC & Biotecanada CEOs and Board Members Meeting March 22, 2019 58
A-2018-01013/LM I would like to obtain a dataset corresponding to "Population of the Federal Public Service by Department and Classification Level". On the open government portal. The period should cover 1990 to 2019 March 20, 2019 12
A-2018-001603 Copies of the following documents: (1) the "emailed statement" from Health Canada that is referred to in the article and which includes the statement
"The non-regulatory counter-proposals that Innovative Medicines Canada and BIOTECanada jointly submitted to the government would not achieve the goal of ensuring appropriate consumer protection in these circumstances.??? It is found at page 3. (2) The document in which the following statements were made (this may be the emailed statement referred to in (1) or it may be a new document): Health Canada also rejected an offer to freeze prescription drug prices, saying it would not meet its objective of lowering prices. Health Canada said the industry had also committed to improving access for patients with rare diseases, but that proposal would not help those who have drug plans. These statements are at the top of page 4. (3) Any other statement or document provided by Health Canada to Reuters in relation to the Reuters article attached to this request. Time Frame is Septembre 01, 2018 to February 06, 2019.
April 4, 2019 93
A-2019-0005631 All information relating to the Patented Medicine Prices Review Board’s (PMPRB) preparation of case 3, case 5 and case 6 that were prepared and published in the context of the PMPRB’s ongoing Guideline Modernization: Case Studies, as found on the PMPRB website. This information includes but is not limited to data, agreements or other information that formed the basis for the case studies and any internal or external correspondence relating to the case studies or the information used in developing them Novembre 14, 2019 362
April 2019 A-2018-00171 Requesting how many veterans have been hired by the Federal Public service under 2015 Veterans Hiring Act (VHA) and/or other Federal Public service initiatives to hire veterans? April 10, 2019 5
A-2018-01269 I would like to receive copies of any data or reports showing the proportion or ratio of advertised and non-advertised executive appointments* in the core public service, broken down by level** and by gender, for each of fiscal years 2015-16, 2016-17 and 2017-18.
*Executive appointments should include both internal promotional appointments and new external hires, substantive appointments only. 
**Levels include EX-01, EX-02, EX-03 and EX-04
April 4, 2019 10
May 2019 A-2018-01413 I seek any documentation which provides a list of all public servants who are part of the EX class job category in the National Capital Region. The list should contain the details: Name of employee, job class, job level, department/agency, location city May 24, 2019 2
A-2019-00095 Briefing note prepared for the President for the month of October 2018: 32664519 - Tabling of the 2017-18 Departmental Results Reports May 21, 2019 2
A-2018-00045/JS3 Time frame: 1 Jan 2008 to 4 July 2018
(1)Final versions of all records stored in any format (including emails, but excluding audio/video records) held by Health Canada relating to any consideration of the selection or rationale for use of the amended Schedule of twelve countries (PMPRB12) set out in the proposed Regulations Amending the Patented Medicines Regulations pre-published in Canada Gazette, Part I,
Vol. 151, No. 48.
(2)To the extent not covered by (1), fmal versions of all records stored in an electronic/machine-readable format held by Health Canada relating to any consideration of the selection or rationale for use of international comparator countries for the purposes of evaluating whether a medicine is being or has been sold at an excessive price in any market in Canada pursuant to the Patent Act by the PMPRB, including:
the original rationale for the PMPRB to use international comparator countries; the selection of the seven countries in the Schedule to the Patented Medicines Regulations, SOR/88-474 and SOR/94-688, as am. (PMPRB7); and any prior or other consideration of altering the PMPRB's use of International comparator countries, including by amendments to the Schedule.
June 12, 2019 160
A-2019-001781 List of individual complaints of excessive drug prices submitted to the Patented Medicine Prices Review Board Canada from January 1st 2009 to May 19th, 2019 July 8, 2019 24
  • All records concerning or related to the federal government's Directive on Automated Decision-Making and that were prepared by or provided to the PMPRB.
  • A list of all pending access to information requests at the PMPRB.
  • All records relating to the impact of the pending amendments on national pharmacare or the impact of national pharmacare on the pending amendments.
  • The agenda and minute for any meetings held by PMPRB executives between 1 January 2018 and 1 May 2019 that concerned the pending amendments.
  • All revisions or redrafts of the Regulatory Impact Analysis Statement (such a document was referred to in one of the emails provided for my request).
  • All records relating to the new basket of countries under the pending amendments, including the inclusion or exclusion of particular countries.
  • All records relating to the adoption of new pricing factors under the pending amendments.
  • All records relating to changes in the reporting requirements for patentees under the pending amendments, especially the requirement to report confidential discounts or rebates.
  • All records relating to a possible decision to distinguish between existing and new medicines in the application of the pending regulations (whether with respect to pricing rules, reporting requirements, or any other legal obligation).
  • All studies, reports, or other documents prepared by or held by the PMPRB and which deal with changes to the content of the pending regulations or the Guidelines which are being developed.
  • All communications regarding the proposed amendments between the PMPRB and one or more of the following organizations: Health Canada, ISED, or CIPO.
  • All letters or other communications received between 1 September 2018 and 1 May 2019 and which question or criticize the pending amendments.
  • All records generated by the PMPRB or another federal government entity that comment on or analyze the report prepared by Mr. David Dodge.
  • A copy of all training presentations concerning the pending amendments and that were held or supposed to be held between 1 September 2019 and 1 May 2019.
June 2019 A-2019-000142/IC Copies of all final briefing notes, memos, emails and other correspondence at the DM level (and above), SPB, CPAB and HECSB regarding the proposed regulatory changes to the PMPRB between October 1, 2018 and April 17, 2019. Exclude potential Cabinet confidences, and any materials that would require third party consultation June 25, 2019 16
A-2019-00302 Briefing note prepared for the Secretary for the month of April 2019: 34366105 - Discussion at Deputy Ministers' Breakfast July 5, 2019 16
July 2019 A-2019-00304 Briefing note prepared for the Secretary for the month of April 2019: 34184112 - Request for Departmental Service Inventories July 9, 2019 28
A-2019-00136/JA All memos and briefing notes prepared for the Minister of Health, Deputy Minister or Assistant Deputy Minister from January 1, 2019 to March 31, 2019 about Procysbi, Cystagon or cysteamine. August 1, 2019 24
A-2017-00396/BH MECS 15-075659-166 (HPFB)
Meeting with AstraZeneca on Feb 22 at 1pm
August 23, 2019 5
August 2019 A-2018-001535/GH All records including recordings, emails, invoices and receipts related to Minister Ginette Petitpas Taylor video Christmas or Holiday message to the Department of Health August 27, 2019 4
A-2019-004303 Please provide copies of any and all written and electronic communications (including but not limited to e-mails, presentation slides, hand-written notes, memos, text messages, and letters) sent between lobbyists representing Schering Plough Canada Inc. and the Patented Medicine Prices Review Board. Date range: January 1 2005 to May 1 2010. October 11, 2019 537
September 2019 A-2019-00316 Intellectual Property: Copy of letters and any communications related to the proposed new regulations for the Patented Medicine Prices Review Board September 11, 2019 1
A-2019-00430 Provide a report in MS Excel format (.xls or .xlsx) from the Position Classification Information System (PCIS+) that includes every position from all departments in an occupational group represented by the PSAC (that is, AS, CM, CR, DA, IS, OE, OM, PM, ST, WP, FR, GL, GS, HP, HS, LI, PR-S, SC, DD, EG, GT, PI, PY, TI, ED, EU, LS, and FB). For greater clarity, the report type should be the PCIS "detailed report", which includes at least the following columns: Department, position number, classification, Title - English, Title - French, job number, supervisor position number, supervisor classification, province, geographic location, branch, previous classification, reason, int. type, sup. factor, evaluation process, auth., effective date, auth. date, rev. date, NOC, vacancy, coordinates by factor (coord1 to coord16), points by factor (points1 to points16), and total points’’ October 2, 2019 7
A-2019-00485 Percentage of public service employees by department or agency in the core public administration who have self-identified for employment equity purposes, as of March 31, 2018 September 3, 2019 2
October 2019 A-2019-001071 The PMPRB Annual Report for 2018 submitted to the Minister of Health pursuant to s.89 of the Patent Act. 2. The date on which the report was submitted to the Minister of Health. October 9, 2019 1
A-2019-00585 Table A1: distribution of public service of Canada employees by designated group according to department or agency contained in the report: Employment Equity in the Public Service of Canada for Fiscal Year 2017 to 2018 presents employment equity data by department and by designated group. The Note at the bottom of this table states: The sum of the designated groups does not equal the total (“all employees”) because employees may have chosen to self-identify in more than one designated group By counting each employee once versus against multiple designated groups, I am seeking confirmation of the total number of public service employees who have self-identified by the same departmental structure as presented in Table 1A referenced above for this same time period October 30, 2019 2
A-2019-00491 Regarding full-time permanent employees. Broken down by institution provide: (A) number of employees (B) how many earn less than $100,000 (C) how many earn more than $100,000 (D) how many earn more than $150,000 (E) how many earn more than $200,000 (F) how many earn more than $250,000 (G) how many earn more than $300,000 (H) how many earn more than $345,400 Provide two versions of this information one for 2017-18 and a second for 2018-19 October 30, 2019 4
November 2019 A-2017-00500 All documents that identify institutions that are not in compliance with the requirements for the publication of Info Source (preferences, a list) as well as the deadlines set for compliance November 8, 2019 3
December 2019 Nothing to Report

Page details

Date modified: